Long-Term Survival of Patients with Ischemic Heart Disease After Surgical Correction of Moderate Ischemic Mitral Regurgitation

Aim: to assess effect of correction of moderate ischemic mitral regurgitation (IMR) in patients with ischemic cardiomyopathy (IMC) in immediate and remote period. Materials and methods. We included in a single center prospective study 76 patients with IMC, left ventricular ejection fraction ≤35 %, and moderate IMR. Patients with indications to postinfarction aneurism repair were not included. For randomization we used the method of envelopes. Thirty-eight patients were randomized in the group where coronary artery bypass grafting (CABG) was combined with of mitral valve repair (MVR), and 38 patients in the control group of isolated CABG. Mean age of patients was 57±8 (from 30 to 75 лет) years. For IMR correction we used rigid MEDENG ring. Results. Inhospital mortality was 5.4 % (n=2) after isolated CABG and 10.81 % (n=4) after CABG + MVR. Main cause of death was acute heart failure. One- and 2‑year survival was 84 and 78 %, respectively, after CABG+MVR, and 84 and 71 % after isolated CABG. There was significant difference in three-year survival between groups (hazard ratio [HR] of death 0.457, p=0.04). Five-year survival was 45 and 74 % after isolated CABG and CABG+MVR, respectively (р=0.037). Factors associated with inhospital mortality were pulmonary hypertension (HR 2.177, 95 % confidence interval [CI] 2.299 to 9.831; p=0.043), NYHA class IV chronic heart failure (HR 3.027, 95 % CI 1.605 to 5.707; р=0.001), negative result of stress test echocardiography (HR 0.087, 95 %CI 0.041 to 0.186; р<0.001), atrial fibrillation (HR 4.754, 95 %CI 2.299 to 9.831; р<0.001). Conclusion. Correction of moderate IMR in patients with IMC leads to improvement of parameters of survival in remote period. Five-year survival after isolated CABG was 45 %, while after CABG+MVR – 74 % (р=0.037).

1. Virk SA, Tian DH, Sriravindrarajah A, Dunn D, Wolfenden HD, Suri RM et al. Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Metaanalysis of clinical and echocardiographic outcomes. The Journal of Thoracic and Cardiovascular Surgery. 2017;154(1):127–36. DOI:10.1016/j.jtcvs.2017.03.039

2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. Heart Disease and Stroke Statistics-2011 Update: A Report From the American Heart Association. Circulation. 2011;123(4):e18–209. DOI:10.1161/CIR.0b013e3182009701

3. Krishnaswamy A, Marc Gillinov A, Griffin BP. Ischemic mitral regurgitation: pathophysiology, diagnosis, and treatment. Coronary Artery Disease. 2011;22(5):359–70. DOI:10.1097/MCA.0b013e3283441d3f

4. Petrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA et al. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic DysfunctionClinical Perspective: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). Circulation. 2016;134(18):1314–24. DOI:10.1161/CIRCULATIONAHA.116.024800

5. Cherniavsky A.M., Efendiyev V.U., Ruzmatov T.M. Mitral valve repair and isolated coronary artery bypass grafting in ischemic cardiomyopathy and moderate mitral insufficiency. Circulation Pathology and Cardiac Surgery. 2015;19(1):15–20.

6. Zhang Y, Ma L, Zhao H. Efficacy of Mitral Valve Repair as an Adjunct Procedure to Coronary Artery Bypass Grafting in Moderate Ischemic Mitral Regurgitation: A Meta-Analysis of Randomized Trials. Journal of Cardiac Surgery. 2015;30(8):623–30. DOI:10.1111/jocs.12585

7. Bouma W, van der Horst ICC, Wijdh-den Hamer IJ, Erasmus ME, Zijlstra F, Mariani MA et al. Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches. European Journal of Cardio-Thoracic Surgery. 2010;37(1):170–85. DOI:10.1016/j.ejcts.2009.07.008

8. Nappi F, Nenna A, Spadaccio C, Lusini M, Chello M, Fraldi M et al. Predictive factors of long-term results following valve repair in ischemic mitral valve prolapse. International Journal of Cardiology. 2016;204:218–28. DOI:10.1016/j.ijcard.2015.11.137

9. Fattouch K, Sampognaro R, Speziale G, Salardino M, Novo G, Caruso M et al. Impact of Moderate Ischemic Mitral Regurgitation After Isolated Coronary Artery Bypass Grafting. The Annals of Thoracic Surgery. 2010;90(4):1187–94. DOI:10.1016/j.athoracsur.2010.03.103

10. Fattouch K, Guccione F, Sampognaro R, Panzarella G, Corrado E, Navarra E et al. POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138(2):278–85. DOI:10.1016/j.jtcvs.2008.11.010

11. Virk SA, Tian DH, Sriravindrarajah A, Dunn D, Wolfenden HD, Suri RM et al. Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Metaanalysis of clinical and echocardiographic outcomes. The Journal of Thoracic and Cardiovascular Surgery. 2017;154(1):127–36. DOI:10.1016/j.jtcvs.2017.03.039